The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Subependymal giant cell tumors in tuberous sclerosis complex
Abstract
OBJECTIVES: To describe the clinical presentations, radiologic features, and postoperative outcomes of a clinic-based population of patients with subependymal giant cell tumors (SGCT) and tuberous sclerosis complex (TSC) and to redefine and reclassify SGCT based on radiologic, clinical, and pathologic criteria. METHODS: Of 134 TSC patients evaluated from December 2001 to November 2003, 11 (8.2%) had undergone resection of a pathologically confirmed SGCT. The authors reviewed the medical records of each case. Follow-up ranged from 2 months to 36 years. RESULTS: Four were asymptomatic at the time of resection while the other seven presented subacutely with fatigue, decreased appetite, headache, increased seizure frequency, visual field deficit, cognitive decline, or behavioral problems. Poor outcomes occurred in all patients aged 11 years or older at the time of resection. CONCLUSIONS: Subependymal giant cell tumors in patients with TSC appear to be of mixed glioneuronal lineage, and, therefore, the current practice of classifying these tumors as astrocytomas merits revision. The clinical diagnosis of SGCT should be made for subependymal lesions in TSC that are associated with symptoms, papilledema, or radiologic evidence of hydrocephalus or interval growth. A diagnosis of probable SGCT should be made when a lesion has the potential to cause obstruction based on size or location. Annual screening by MRI with or without contrast is indicated until at least 21 years of age even if subependymal nodules are absent on initial imaging. A diagnosis of SGCT or probable SGCT warrants more frequent monitoring or surgical intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuberous Sclerosis Complex Consensus Conference: Revised Clinical Diagnostic Criteria
Roach, E. S., Gomez, M. R., & Northrup, H. (1998) · Journal of Child Neurology · doi:10.1177/088307389801301206 · Cited by 1,081
Dabora, S. L., Jozwiak, S., Franz, D. N., Roberts, P. S., Nieto, A., Chung, J., Choy, Y.-S., Reeve, M. P., Thiele, E., Egelhoff, J. C., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/316951 · Cited by 1,001
Self-citationEpidemiology of Tuberous Sclerosis
OSBORNE, J. P., FRYER, A., & WEBB, D. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb37754.x · Cited by 730
Causes of Death in Patients With Tuberous Sclerosis
SHEPHERD, C. W., GOMEZ, M. R., LIE, J. T., & CROWSON, C. S. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61196-3 · Cited by 555
Jones, A. C., Shyamsundar, M. M., Thomas, M. W., Maynard, J., Idziaszczyk, S., Tomkins, S., Sampson, J. R., & Cheadle, J. P. (1999) · The American Journal of Human Genetics · doi:10.1086/302381 · Cited by 529
Henske, E. P., Neumann, H. P. H., Scheithauer, B. W., Herbst, E. W., Short, M. P., & Kwiatkowski, D. J. (1995) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870130411 · Cited by 264
MORBIDITY ASSOCIATED WITH TUBEROUS SCLEROSIS: A POPULATION STUDY
Webb, D. W., Fryer, A. E., & Osborne, J. P. (1996) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1996.tb12086.x · Cited by 228
National Institutes of Health Consensus Conference: Tuberous Sclerosis Complex
Hyman, M. H., & Whittemore, V. H. (2000) · Archives of Neurology · doi:10.1001/archneur.57.5.662 · Cited by 195
Braffman, B. H., Bilaniuk, L. T., Naidich, T. P., Altman, N. R., Post, M. J., Quencer, R. M., Zimmerman, R. A., & Brody, B. A. (1992) · Radiology · doi:10.1148/radiology.183.1.1549677 · Cited by 191
Subependymal Giant Cell Astrocytoma: A Clinical, Pathological, and Flow Cytometric Study
Shepherd, C. W., Scheithauer, B. W., Gómez, M. R., Altermatt, H. J., & Katzmann, J. A. (1991) · Neurosurgery · doi:10.1227/00006123-199106000-00013 · Cited by 170
Cited by
The Tuberous Sclerosis Complex
Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793
Curatolo, P., Bombardieri, R., & Jozwiak, S. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61279-9 · Cited by 1,088
Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
Krueger, D. A., Care, M. M., Holland, K., Agricola, K., Tudor, C., Mangeshkar, P., Wilson, K. A., Byars, A., Sahmoud, T., & Franz, D. N. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001671 · Cited by 1,006
Franz, D. N., Belousova, E., Sparagana, S., Bebin, E. M., Frost, M., Kuperman, R., Witt, O., Kohrman, M. H., Flamini, J. R., Wu, J. Y., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61134-9 · Cited by 794
Self-citationCentral Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Nabors, L. B., Portnow, J., Ahluwalia, M., Baehring, J., Brem, H., Brem, S., Butowski, N., Campian, J. L., Clark, S. W., Fabiano, A. J., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.0052 · Cited by 539
Metadata
- Authors
- Goh, S., Butler, W., & Thiele, E. A.
- Venue
- Neurology
- Published
- 2004-10-26
- Volume
- 63
- Issue
- 8
- Pages
- 1457-1461
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2112100507
- Cited by
- 262
- References
- 19
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Subependymal giant cell tumors in tuberous sclerosis complex. https://app.cochat.ai/papers/10.1212/01.wnl.0000142039.14522.1a
- The paper
- Goh, S., Butler, W., & Thiele, E. A. (2004). Subependymal giant cell tumors in tuberous sclerosis complex. Neurology. https://doi.org/10.1212/01.wnl.0000142039.14522.1a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.